FDA | Press Releases
Follow
FDA Approves First New Molecular Entity Under National Priority Voucher Program
The U.S. Food and Drug Administration today approved Foundayo (orforglipron) marking the fifth approval under the Commissioner's National Priority Voucher (CNPV) pilot program.
